HP Inc. has appointed Emma Walmsley as its new Chief Executive Officer, effective January 4, 2027. She will succeed interim CEO Bruce Broussard and lead HP as the company looks to capture new opportunities created by artificial intelligence and evolving workplace technologies. Her mandate will include advancing HP’s innovation strategy, identifying new avenues for growth, and bringing the company’s businesses and capabilities together around its next phase of development.
Walmsley most recently served as Chief Executive Officer of GSK, where she held the top role from April 2017 through December 2025. She joined GSK in 2010 and previously led its Consumer Healthcare business, later overseeing a broader transformation centered on specialty medicines, vaccines, research and development, and the separation of Haleon. Before joining GSK, she spent 17 years at L’Oréal in marketing and general management roles across multiple international markets.
Why this matters: HP is entering a leadership transition as AI increasingly reshapes personal computing, workplace technology, and how enterprises use devices and services. Appointing an executive with experience transforming a large global business suggests HP is looking beyond product innovation alone and toward broader organizational and portfolio changes as it pursues its next phase of growth.

Join the conversation on LinkedInConnect with Emma Walmsley on LinkedIn